By Lewis Crofts ( August 18, 2026, 11:39 GMT | Insight) -- French pharmaceutical company Les Laboratoires Servier has started litigation against makers of generic drugs in the Netherlands in a bid to ensure they are on the hook for any damages claims from lawsuits brought by health insurers, Viatris, one of the targeted companies, has said. The European Commission found in 2014 that agreements between Servier and generics manufacturers meant delayed release of cheaper versions of the hypertension drug perindopril.French pharmaceutical company Les Laboratoires Servier has started litigation against makers of generic drugs in the Netherlands in an apparent bid to ensure they are on the hook for any potential damages claims from lawsuits brought by health insurers, Viatris, one of the targeted companies, has said....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.